However, we did not detect TGF-β+ FcεRIα+ ST2+ macrophages or IL-33 expression from the tumor in our IL-33-treated TB mice (data not shown), probably due to the different source of IL-33, that is, exogenous IL-33, in this study. The gene discussed is FCER1A; the disease is neoplasm.